Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009532 |
---|---|
Receipt number | R000011193 |
Scientific Title | Pentraxin 3/sLOX-1 as a markar for early diagnosis of coronary artery abnormality in Kawasaki Disease |
Date of disclosure of the study information | 2013/01/01 |
Last modified on | 2021/06/21 10:05:24 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/12/12 11:50:57 | ||
2 | Update | 2013/01/18 12:30:44 | Research ethics review |
|
3 | Update | 2013/06/12 13:05:59 | Anticipated trial start date |
|
4 | Update | 2013/06/12 20:20:27 | Recruitment status Other related information Other related information |
|
5 | Update | 2013/06/12 20:22:31 | Recruitment status |
|
6 | Update | 2013/06/12 20:22:52 | Recruitment status |
|
7 | Update | 2014/06/12 09:48:06 | Email Co-sponsor Co-sponsor Name of secondary funder(s) Name of secondary funder(s) |
|
8 | Update | 2015/06/12 09:43:43 | Recruitment status Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
9 | Update | 2016/10/27 09:22:13 | Name of primary person or sponsor Institute Organization Organization Organization Category of Funding Organization |
|
10 | Update | 2017/12/18 15:50:26 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
11 | Update | 2019/06/21 17:15:38 | Date of IRB Date analysis concluded |
|
12 | Update | 2019/06/21 17:36:23 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Institute Email3 Organization Organization Address Address Tel |
|
13 | Update | 2020/06/18 10:24:53 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures Plan to share IPD Plan to share IPD IPD sharing Plan description IPD sharing Plan description |
|
14 | Update | 2021/06/21 10:05:24 | Recruitment status |